Abstract
Gold, in a variety of forms, has been used in medicine throughout the history of civilisation. In the twentieth century gold complexes were introduced for the treatment for rheumatoid arthritis, culminating in the introduction of the oral drug Auranofin in 1985. The clinical use and mechanism of action of gold drugs is reviewed here, including recent discoveries on the effect of gold drugs on gene expression. The search for new medical uses of gold is described, focusing on the anticancer and antimicrobial properties of gold compounds.
Similar content being viewed by others
References
G.J. Higby,Gold Bull., 1982,15, 130
R. V. Parish,Interdisc. Sci. Rev., 1992,17, 221
G.D. Champion, G.G. Graham and J.B. Ziegler,Ballieres Clin. Rheumatol, 1990,4, 491
R.E. Thomas and R.A. Papandrea,Med. J Aust., 1993,158, 720
R.V. Parish and S.M. Cottrill,Gold Bull., 1987,20, 3
N.L. Gotclieb,J Rheumatol., 1982,9 (Suppl.8), 99
R.M. Snyder, C.K. Mirabelli and S.T. Crooke,Semin. Arthritis Rheum., 1987,17, 71
T.G. Davis (ed),Scand. J RheumatoL, Supplement 63, 1986
P.J. Sadler,Struct. Bonding, 1976,29, 171
C.P. Shaw III,Inorg. Persp. Biol. Med., 1979,2, 278
D.H. Brown and W.E. Smith,Chem. Soc. Rev., 1980,9, 217
C.P. Shaw III,Comments Inorg. Chem., 1989,8, 233
D.T. Walz, M.J. Dimartino and D.E. Griswold,J Rheumatol 1982,9, Suppl. 8, 54
M.L. Handel, C.K.W. Watts, A. dePazio, R.O. Day and R.L. Sutherland,Proc. Natl. Acad Sci. USA, 1995,92, 4497
O.M. Ni Dhubhghaill and P.J. Sadler, in ‘Metal Complexes in Cancer Chemotherapy’, ed. B.K. Keppler, VCH, Weinheim, 1993, p. 221.
C.P. Shaw III, in ‘Metal Compounds in Cancer Therapy’, ed. S.P. Pricker, Chapman and Hall, London, 1994, p. 46
C.K. Mirabelli, R.K. Johnson, S.T. Crooke, M.R. Mattern, S.M. Mong, C.M. Sung, G. Rush, S.J. Berners-Price, P.S. Jarrett and P.J. Sadler, in ‘5th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy’, ed. M. Nicolini and G. Bandoli, Cleup, Padua, Italy, 1987, p. 319
S.J. Berners-Price, P.S. Jarrett and P.J. Sadler,Inorg. Chem., 1987,26, 3074
G.D. Hoke, R.A. Macia, P.C. Meunier, P.J. Bugelski, C.K. Mirabelli, G.P. Rush and W.D. Matthews,Toxicol. Appl. Pharmacol., 1989,100, 293
M. Viotte, B. Gautheron, M.M. Kubicki, I.E. Nifant'ev and S.P. Pricker,Metal Based Drugs, 1995,2, 311
R.V. Parish, B.P. Howe, J.P. Wright, J. Mack, R.G. Pritchard, R.G. Buckley, A.M. Elsome and S.P. Pricker,Inorg. Chem., 1996,35, 1659
S.P. Pricker, in ‘Metal Ions in Biology and Medicine’, ed. Ph. Collery, L.A. Poirier, M. Manfait and J-C. Etienne John Libby Eurotext, Paris, 1990, p. 452
A.M. Elsome, PhD Thesis, King's College, London, 1995
J.H. Liebarth and R.H. Persellin,Agents and Actions, 1981,11, 458
L. Girgis, P.G. Conaghan and P. Brooks,Curt: Opin. Rheumatol, 1994,6, 252
M.D. Rhodes, P.J. Sadler, M.D. Scawen and S. Silver,J. Inorg. Biochem., 1992,46, 129
W. Brumfitt, J.M.T. Hamilton-Miller,Drugs Exptl. Clin. Res., 1990,16, 205
A.M. Elsome, W Brumfitt, J. M. T. Hamilton-Miller, P.D. SavageR, O. King and S.P.P ricker, in ‘Program and Abstracts of the 31st Interscience Conference on Anti-Microbial Agents and Chemotherapy, Chicago’, American Society for Microbiology,Washington, DC, 1991, Abstract 387, p. 163
A.M. Elsome, J.M.T. Hamilton-Miller, W. Brumfitt and W.C. Noble, J.Antimicrob. Chemother., 1996,37, 911
R.V. Parish, J. Mack, L. Hargreaves, J.P. Wright, R.G. Buckley, A.M. Elsome, S.P. Fricker and B.R.C. Theobald,J. Chem. Soc., Dalton Trans., 1996, 69
Author information
Authors and Affiliations
Additional information
Dr Simon Fricker is a Principal Scientist in the Biomedical Technology Department at the Johnson Matthey Technology Centre, where he has been responsible for pharmacology and toxicology for 12 years, on the research and development of novel inorganic pharmaceuticals.
Rights and permissions
About this article
Cite this article
Pricker, S.P. Medical uses of gold compounds: Past, present and future. Gold Bull 29, 53–60 (1996). https://doi.org/10.1007/BF03215464
Issue Date:
DOI: https://doi.org/10.1007/BF03215464